Active	Status	Sponsor type	Region	Phase	Filter
1 Active 3 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
pizuglanstat (TAS-205) / Otsuka
NCT04587908: A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD）	Recruiting	3	100	Japan	TAS-205 [Ambulatory Cohort] [Non-ambulatory Cohort], Placebo [Ambulatory Cohort] only	Taiho Pharmaceutical Co., Ltd.	Duchenne Muscular Dystrophy	05/27	05/27